KGMU reels under shortage of medicines, Hepatitis C patients suffer
Nodal officer for the Hepatitis control campaign at KGMU, Prof Sumit Rungta explained that the current stock of medicine is inadequate to meet the demands of both existing and new Hepatitis C patients.
Lucknow: With medicines out of stock, patients suffering from the Hepatitis C virus (HCV) who come to King George's Medical University (KGMU) here, hoping to receive free treatment for their condition, are being forced to turn back or purchase medicines from the open market at a cost of around Rs 8,000-10,000.
Also Read:KGMU ward boy terminated for allegedly misbehaving with nurse
The university receives drugs from the Centre under the National Health Mission (NHM), but the existing stock is only sufficient for old patients.
Officials mentioned that the new stock was expected to arrive 30 days ago but did not. KGMU officials have submitted a request letter to the NHM addressing the urgent need to replenish the medicine stock.
A typical course of treatment for HCV at KGMU lasts three months, which emphasizes the importance of the timely arrival of the medicine to begin treatment for new patients.
Nodal officer for the Hepatitis control campaign at KGMU, Prof Sumit Rungta explained that the current stock of medicine is inadequate to meet the demands of both existing and new Hepatitis C patients.
“We are distributing medication solely to registered patients, ensuring their treatment remains uninterrupted.”
Unfortunately, this situation has left new patients disappointed and in urgent need of treatment.
When contacted, the nodal officer for the state Hepatitis control programme, Vikasendu Agrawal said, “The demand has been made to the Central government and fresh stock is likely to arrive from Madhya Pradesh, Telangana, Gujarat and West Bengal in a day or two.”
He said that he was not aware of the exact reason for the delay, but it could be an issue in the supply chain or tendering process.
Also Read:KGMU doctor found running private hospital, HC notice to institute administration
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.